Novartis, Bristol Myers Put Autoimmune CAR-T Trials on Ice as Safety Fears Explode
Novartis and Bristol Myers pause CAR-T autoimmune trials after patient deaths and severe side effects spark safety concerns.
Two big medicine companies stopped testing a new kind of treatment because some patients got very sick or died. When companies pause experiments to keep people safe, it shows they take health seriously—but it also means that treatment won't help patients as quickly as hoped.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.